Purchase Order 75D30124P20254

Award Date 9/23/24
Potential Completion Date 12/31/24
Potential Value $54K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $248,971.98 firm fixed price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Luminex Corp, a foreign-owned for-profit manufacturer of biological testing technologies. The contract is for the provision of Luminex Beads, with no set-aside designation. Luminex is a prime contractor that provides specialized multiplex diagnostic platforms, assays, reagents, and services to federal agencies including the CDC, VA, DHA,...
The U.S. Department of Health and Human Services Centers for Disease Control and Prevention awarded a Purchase Order to Luminex Corp, a foreign-owned for-profit manufacturer of biological testing technologies, for MAGPLEX-C MICROSPHERES. The firm fixed-price contract has a potential value of $146,376.08 and will be performed in Atlanta, GA. The contract does not have a set-aside designation. Luminex Corp is known for providing proprietary testing platforms, assay kits, reagents, software, and...
This is a $20,791.54 firm-fixed price purchase order awarded to Luminex Corp, a foreign-owned, for-profit manufacturer of biological testing technologies. The contract is for the delivery of MICROSPHERE, MAGPLEXAVIDIN, REG 026, 1ML to the Centers for Disease Control and Prevention (CDC) in Pittsburgh. The contract has a completion date of September 30, 2024 and was awarded on September 12, 2024. There is no set-aside designation for this award. Luminex has provided various diagnostic testing...
This is a $97,636.38 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Luminex Corp, a manufacturer of biological testing technologies including multiplex diagnostic solutions. The contract is for the provision of lab supplies, and is not set aside. Luminex has previously provided the CDC, as well as other federal agencies like the Department of Veterans Affairs and Department of Defense, with immunology services, laboratory supplies,...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $241,355.50 firm fixed price purchase order to Luminex Corporation, a foreign-owned for-profit manufacturer of biological testing technologies. The contract is for the provision of lab supplies, with no set-aside designation, and a completion date of October 1, 2021. Luminex is a provider of proprietary multiplex diagnostic solutions to federal agencies, including the CDC, Department of Veterans...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $92,772.80 firm-fixed-price purchase order contract to Luminex Corporation, a manufacturer of biological testing technologies and diagnostic solutions. The contract does not have a set-aside designation. Luminex has previously provided immunology services, laboratory supplies, reagents, multiplexing equipment, maintenance, and diagnostic testing products to various federal agencies, including the CDC, Department of Veterans...
This is a firm fixed-price purchase order issued by the Centers for Disease Control and Prevention (CDC) to Luminex Corporation, a manufacturer of biological testing technologies. The contract, valued at $95,567.12, is for the procurement of Luminex Microspheres. Luminex often serves as a prime contractor for the CDC, Department of Veterans Affairs, Department of Defense, and other federal agencies, providing specialized multiplexing systems and diagnostic testing products. While this award does...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Luminex Corp, a manufacturer of biological testing technologies and diagnostic solutions, for LUMINEX 200 SERVICE. The $23,850.00 contract has a ceiling value and an ultimate completion date of July 7, 2027. This award does not utilize a set-aside mechanism. Luminex Corp, a foreign-owned, for-profit manufacturer, has provided specialized multiplexing systems, assay kits, reagents, and...
This $55,458.60 firm fixed price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Luminex Corporation, a manufacturer of biological testing technologies, to provide laboratory supplies. The contract does not have a set-aside designation. Luminex has previously received prime and subcontract awards from various federal agencies, including the Department of Veterans Affairs, Department of Defense, and National Institutes of Health, to deliver immunology...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $148,550.00 firm fixed price purchase order to Luminex Corporation, a for-profit foreign-owned manufacturer, for a Gastrointestinal Pathogen Panel. This competitive contract does not utilize a set-aside. Luminex provides proprietary multiplexing technologies, diagnostic assays, and related products to support clinical testing and biomedical research efforts across various federal agencies including...

This is a $54,350.44 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Luminex Corp, a foreign-owned for-profit manufacturer of biological testing technologies. The contract is for the procurement of Luminex's proprietary MagPlex-C Microsphere Beads, which are a specialized laboratory instrument used in the CDC's serological assays to quantify antibodies for public health surveillance. The CDC requires these beads due to their compatibility with the agency's existing assay technology, and Luminex is the sole manufacturer capable of providing them at the necessary scale. This procurement is not designated as a set-aside. The contract has a period of performance through December 31, 2024, with the work to be performed in Atlanta, GA. Luminex has previously served as a prime and subcontractor to the CDC, providing specialized multiplexing systems, assay kits, reagents, and other diagnostic testing products to support the agency's clinical testing programs and biomedical research efforts.

Generated 1/1/25, 9:15 AM